Fred Alger Management, LLC Provention Bio, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$11.79 - $18.94 $356,164 - $572,158
-30,209 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$10.34 - $15.2 $152,938 - $224,823
-14,791 Reduced 32.87%
30,209 $388,000
Q2 2020

Aug 14, 2020
BUY
$7.81 - $17.0 $296,780 - $646,000
38,000 Added 542.86%
45,000 $635,000
Q1 2020

May 15, 2020
BUY
$5.42 - $17.75 $37,940 - $124,250
7,000 New
7,000 $64,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email